News & Events

• April 7, 2021
  

  Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy Abstract WMS 2020

• April 7, 2021
  

  Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy poster WMS 2020

• April 7, 2021
  

  Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Abstract WMS 2019

• April 7, 2021
  

  Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Poster WMS 2019

• January 19, 2021
  

  C-Path’s PKDOC Presentation on Fluid-Based Biomarkers

  Critical Path Institute’s John-Michael Sauer, Ph.D. presents information on fluid-based biomarkers and how they can be applied to help advance polycystic kidney disease drug development for patients across the globe. C-Path’s Polycystic Kidney Disease Outcomes Consortium investigates tools and promotes research that will lead to the development and regulatory approval of new therapies for PKD. Watch now: https://youtu.be/4OXEMYXpOvI...